Suppr超能文献

双齿丙二酸酯配体对L1210细胞系中铂化合物利用及细胞毒性的影响。

Effects of the bidentate malonate ligand on the utilization and cytotoxicity of platinum compounds in the L1210 cell line.

作者信息

Mauldin S K, Husain I, Sancar A, Chaney S G

出版信息

Cancer Res. 1986 Jun;46(6):2876-82.

PMID:3698013
Abstract

Previous studies have investigated the cytotoxicity of platinum(II) compounds with bidentate leaving ligands, but little is known about their uptake or mechanism of action inside the cell. We have compared the uptake and intracellular effects of cis-1,2-diaminocyclohexanemalonatoplatinum(II) [Pt(mal)(cis-DACH)] and cis-1,2-diaminocyclohexanedichloroplatinum(II) [PtCl2(cis-DACH)] in the L1210 cell line. In the 3-h colony formation assay, PtCl2(cis-DACH) is almost 10 times more cytotoxic than Pt(mal)(cis-DACH). However, when the time of incubation with platinum drug is increased from 3 to 24 h the cytotoxicity of PtCl2(cis-DACH) changes relatively little while the cytotoxicity of Pt(mal)(cis-DACH) increases over 10-fold. As a consequence, Pt(mal)(cis-DACH) is only slightly less cytotoxic than the dichloro compound by 24 h. These data can readily be explained by differences in the time course of uptake. Pt(mal)(cis-DACH) is initially taken by the cell at a much slower rate than PtCl2(cis-DACH), but the uptake continues linearly for at least 24 h with the malonate compound, while uptake for the dichloro compound begins to plateau between 5 and 8 h. The earlier plateauing of PtCl2(cis-DACH) uptake is most likely to be due to a quicker approach to equilibrium between intracellular and extracellular concentrations of unchanged drug which is caused by a more rapid inactivation of PtCl2(cis-DACH) in the media coupled with the more rapid uptake of PtCl2(cis-DACH) by the cells. When compared at equal cytotoxicity, the uptake of platinum into the intracellular pool of low molecular weight platinum compounds is significantly greater for Pt(mal)(cis-DACH) even though the rate of platinum incorporation into DNA is essentially the same for both compounds at early times. These data suggest that a smaller percentage of the low molecular weight platinum is in a reactive form inside the cell for Pt(mal)(cis-DACH). While the inhibition of cell survival exactly parallels incorporation of platinum into DNA for both compounds, there is a significant lag before the onset of inhibition of DNA synthesis for Pt(mal)(cis-DACH). This observation suggests that the conversion of monoadducts to diadducts may be slower for platinum compounds with bidentate leaving ligands.

摘要

以往的研究调查了带有双齿离去配体的铂(II)化合物的细胞毒性,但对于它们在细胞内的摄取情况或作用机制却知之甚少。我们比较了顺式-1,2-二氨基环己烷丙二酸铂(II)[Pt(mal)(cis-DACH)]和顺式-1,2-二氨基环己烷二氯铂(II)[PtCl2(cis-DACH)]在L1210细胞系中的摄取情况和细胞内效应。在3小时集落形成试验中,PtCl2(cis-DACH)的细胞毒性几乎是Pt(mal)(cis-DACH)的10倍。然而,当铂药物的孵育时间从3小时增加到24小时时,PtCl2(cis-DACH)的细胞毒性变化相对较小,而Pt(mal)(cis-DACH)的细胞毒性增加了10倍以上。因此,到24小时时,Pt(mal)(cis-DACH)的细胞毒性仅比二氯化合物略低。这些数据很容易用摄取时间进程的差异来解释。Pt(mal)(cis-DACH)最初被细胞摄取的速度比PtCl2(cis-DACH)慢得多,但丙二酸化合物的摄取至少持续24小时呈线性,而二氯化合物的摄取在5到8小时之间开始趋于平稳。PtCl2(cis-DACH)摄取较早趋于平稳很可能是由于细胞内和细胞外未变化药物浓度之间更快地达到平衡,这是由培养基中PtCl2(cis-DACH)更快地失活以及细胞对PtCl2(cis-DACH)更快地摄取所导致的。当在同等细胞毒性下进行比较时,即使在早期两种化合物将铂掺入DNA的速率基本相同时,Pt(mal)(cis-DACH)进入低分子量铂化合物细胞内池的铂摄取量也显著更高。这些数据表明,对于Pt(mal)(cis-DACH),细胞内低分子量铂中以反应性形式存在的比例较小。虽然两种化合物对细胞存活的抑制与铂掺入DNA的情况完全平行,但对于Pt(mal)(cis-DACH),在DNA合成抑制开始之前有一个明显的延迟。这一观察结果表明,对于带有双齿离去配体的铂化合物,单加合物向双加合物的转化可能较慢。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验